Get The Spin Brief
CRISPRMRIimmunotherapyclinical trialorganoidsbiological age
Technology explainer

mRNA medicines

Temporary genetic instructions that let the body’s own cells make a protein.

Maturity: Approved in some uses
Abstract editorial illustration of stylised immune cells in cyan surrounding violet tumor cells, with molecular shapes suggesting targeted drugs; an original illustration, not a microscope image.
Original illustration by Spin Pharma.

How it works

A strand of messenger RNA, wrapped in a lipid nanoparticle, enters cells and is read by ribosomes to make a target protein — for a vaccine, typically a piece of a virus, so the immune system learns to recognise it. The mRNA breaks down naturally.

Why it matters

mRNA can be designed and manufactured quickly, which is why it is being tested beyond infectious disease, including individualised cancer vaccines.

Limits & open questions

Delivery beyond the liver and muscle is hard, some uses need repeated dosing, and cancer applications remain investigational until late-stage trials report.

Related

Stories about this technology

Abstract editorial illustration of a DNA double helix unspooling into lines of glowing letters, some highlighted and some faded to suggest known and unknown meaning.Genome + Cells
Mixed / overview

Decode the Genome: What Sequencing Can Tell Us—and What It Cannot

From the $3 billion Human Genome Project to routine sequencing, reading DNA has become easy. Here is what a genome can reveal today, and where uncertain variants, risk scores and missing context set hard limits.

Explainer5 min read